Epigenetic therapy in immune-oncology

PA Jones, H Ohtani, A Chakravarthy… - Nature Reviews …, 2019 - nature.com
DNA methylation inhibitors have become the mainstay for treatment of certain
haematological malignancies. In addition to their abilities to reactivate genes, including …
被引用次数：418 相关文章

Epigenetic therapy in immune-oncology

PA Jones, H Ohtani, A Chakravarthy… - Nature reviews …, 2019 - pubmed.ncbi.nlm.nih.gov
DNA methylation inhibitors have become the mainstay for treatment of certain
haematological malignancies. In addition to their abilities to reactivate genes, including …
[PDF] researchgate.net

[PDF][PDF] Epigenetic therapy in immune-oncology

PA Jones, H Ohtani, A Chakravarthy… - Nature reviews … - researchgate.net
DNA methylation inhibitors have become the mainstay for treatment of certain
haematological malignancies. In addition to their abilities to reactivate genes, including …

Epigenetic therapy in immune-oncology

PA Jones, H Ohtani, A Chakravarthy… - Nature Reviews …, 2019 - go.gale.com
DNA methylation inhibitors have become the mainstay for treatment of certain
haematological malignancies. In addition to their abilities to reactivate genes, including …

Epigenetic therapy in immune-oncology.

PA Jones, H Ohtani, A Chakravarthy… - Nature reviews …, 2019 - europepmc.org
DNA methylation inhibitors have become the mainstay for treatment of certain
haematological malignancies. In addition to their abilities to reactivate genes, including …

[引用][C] Epigenetic therapy in immune-oncology

PA Jones, H Ohtani, A Chakravarthy… - Nature Reviews …, 2019 - cir.nii.ac.jp